Capital that Translates
Great science into
tomorrow’s Healthcare
Eckuity Capital is a growth equity investor providing strategic capital to companies across the healthcare sector. We pursue investments with strong commercial viability and a clear exit pathway whilst keeping a patient centric approach to our portfolio design and construction.
We invest across three major verticals: MedTech, HealthTech and BioTech Services.
Across MedTech and HealthTech, our focus areas range from surgical, cardiovascular, biomarkers and diagnostics to provider operations, alternative care, tech-enabled services and billing and coding. Across Biotech Services, our focus includes analytics, R&D tools, process and quality control as well as clinical trial enablement.
Our investments are designed to deliver returns to investors and to society. Innovation that provides better outcomes for patients, higher productivity for providers and lower costs for the system, thereby democratizing access to healthcare globally.
We bring significant value to our portfolio companies by ensuring that their technologies can be commercialized as quickly as possible. We often play an active role in assisting our companies with business leads, opening new markets, partnering with hospitals and commercial organizations, as well as opening international markets.
Investing With
Positive Impact
We focus on Impact in two ways; by investing in technology that will have significant influence on healthcare but also in companies who embody strong societal values.
Impact ON HEALTHCARE
Better outcomes
Better outcomes means an improvement on the current ability to treat or manage a disease or condition. Better outcomes can be achieved either by increasing efficacy or improving efficiency over a current treatment or by developing an entirely new treatment for a currently untreatable disease. Better outcomes can also be achieved by developing new treatments with lower side-effects. Side effects cause treatment drop-outs or limit who can benefit.
Wider access
Treatments are often available but with limited access to a small number of people. We look for ways to broaden access:
Distribution – creating new access points for patients like secure online delivery, telemedicine and digital therapeutics.
Formulation enhancements can lead to greater access by making treatment simpler. A pill taken at home is more accessible than having to wait for a specialist hospital-based team for surgery.
Data and AI can be used to better understand who will benefit most from a treatment, creating greater access.
Lower cost
Cost reduction can take many forms: lower manufacturing costs to eliminating the need to refrigerate storage, to reducing the cost of giving the treatment eg a pill cost less to administer than an intravenous infusion.
The cost to develop a new drug/treatment is rising exponentially, however new technology, data and AI can speed discovery, identify the precise patients for treatment to reduce the size of clinical trials and reduce the risk of costly failures.
A culture for good
We look for management and founders that not only make impact part of their business delivery but also build impact values into their culture and business practices. We believe companies play a vital role in society as engines of creativity, innovation and economic opportunity, as well as shaping the future of sustainability.
Business with purpose
We support the Businesses with Purpose movement and encourage our partners to: Deliver value to the market, Invest in employees, Deal fairly and ethically with suppliers, Support the communities in which they work and Generate long-term value for shareholders.
Responsible development
We look for companies that are developing products that keep both environmental and human safety in mind. We ensure they contribute to practices that help conserve resources like water and energy or that actively build sustainability into their business models in the form of recycling/waste programs, carbon offsetting and ecofriendly development.
